MEGHAN SRI KARUTURI to Prospective Studies
This is a "connection" page, showing publications MEGHAN SRI KARUTURI has written about Prospective Studies.
Connection Strength
0.133
-
Measures of functional status in older patients treated with palbociclib for advanced breast cancer. J Geriatr Oncol. 2024 Jan; 15(1):101670.
Score: 0.082
-
Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study. Breast Cancer Res Treat. 2024 Feb; 203(3):463-475.
Score: 0.020
-
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer. Invest New Drugs. 2021 04; 39(2):509-515.
Score: 0.016
-
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer. Oncologist. 2019 06; 24(6):762-771.
Score: 0.015